Wednesday, June 16, 2010

Second Generation Sequencing of the Mesothelioma Tumor Genome

The current paradigm for elucidating the molecular etiology of cancers relies on the interrogation of small numbers of genes, which limits the scope of investigation. Emerging second-generation massively parallel DNA sequencing technologies have enabled more precise definition of the cancer genome on a global scale. We examined the genome of a human primary malignant pleural mesothelioma (MPM) tumor and matched normal tissue by using a combination of sequencing-by-synthesis and pyrosequencing methodologies to a 9.6X depth of coverage...

(this Post content was reproduced from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0010612)